Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.

Website: psylo.bio

Employees: 5 - 9

HQ: N/A

Location: Sydney, N/A, AU

Revenue: Not Available

Looking for contact information for Psylo? Look no further than ConnectPlex! Our comprehensive B2B lead generation platform provides you with the most up-to-date and accurate contact information for Psylo and millions of other companies across the globe. Our user-friendly interface makes it easy to search, filter, and connect with the right people in just a few clicks. Whether you're looking to expand your business, collaborate with partners, or find new customers, ConnectPlex is the perfect solution for all your business needs. At ConnectPlex, we understand the importance of accurate and reliable contact information. That's why we've developed a sophisticated algorithm that ensures our data is always up-to-date and verified. Our team of experts works tirelessly to provide you with the most comprehensive and accurate contact information for Psylo and other companies, so you can focus on growing your business. With ConnectPlex, you'll never have to worry about wasting time searching for contact information again. Start connecting with the people that matter today

Psylo is a cutting-edge drug development company based in Sydney, Australia. With a focus on next-generation psychedelics, their mission is to revolutionize the way we treat mental health disorders. The company's co-founders, Sam Banister and Joshua Ismin, bring a wealth of expertise in the fields of science and biotechnology to the table. Psylo's goal is to create broadly accessible medicines that are superior to currently available SSRI medications. They believe that psychedelic molecules hold the key to unlocking new and effective treatments for a range of mental health conditions. By building a pipeline of novel molecules, Psylo is committed to taking leading candidates through to clinical trials. With their innovative approach and dedication to advancing the field of mental health treatment, Psylo is poised to make a significant impact in the years to come.

Psylo is a company that wants to make new and better medicines for people who are struggling with their mental health. They want to use special molecules called psychedelics to create these medicines. These molecules have the potential to be more effective and safer than the medicines that are currently available. The company is working to create a group of new medicines that they can test in clinical trials to see if they are safe and effective. They hope that these new medicines will be able to help people feel better and improve their mental health.